Krystal Biotech buy The Goldman Sachs Group, Inc.
Start price
20.11.23
/
50%
€96.00
Target price
20.11.24
€146.38
Performance (%)
74.90%
Price
10.09.24
€167.90
Summary
This prediction is currently active. With a performance of 74.90% the BUY prediction by The_Goldman_Sachs_Gr is a big success. This prediction currently runs until 20.11.24. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Krystal Biotech | -0.768% | -0.768% |
iShares Core DAX® | -1.611% | 3.135% |
iShares Nasdaq 100 | -0.500% | 0.775% |
iShares Nikkei 225® | -1.483% | 4.610% |
iShares S&P 500 | -0.501% | 1.914% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Krystal Biotech diskutieren
Krystal Biotech, Inc. (NASDAQ: KRYS) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $160.00 price target on the stock.
Ratings data for KRYS provided by MarketBeat